2021

1. Konno M, Osawa T, Hotta K, Shimizu A, Abe T, Matsumoto R, Kikuchi H, Shinohara N: Primary renal
leiomyosarcoma with a tumor thrombus in the inferior vena cava. IJU Case Rep. 2021 Nov; 5 (1): 66-69.
[5y-IF: N/A]
2. Nishioka K, Gotoh K, Hashimoto T, Abe T, Osawa T, Matsumoto R, Yokota I, Katoh N, Kinoshita R, Yasuda K,
Yakabe T, Yoshimura T, Takao S, Shinohara N, Aoyama H, Shimizu S, Shirato H: Are simple verbal instructions
sufficient to ensure that bladder volume does not deteriorate prostate position reproducibility during spot
scanning proton therapy? BJR Open. 2021 Nov; 3 (1): 20210064. [5y-IF: N/A]
3. Shiota M, Terada N, Kitamura H, Kojima T, Saito T, Yokomizo A, Kohei N, Goto T, Kawamura S, Hashimoto

Y, Takahashi A, Kimura T, Tabata KI, Tomida R, Hashimoto K, Sakurai T, Shimazui T, Sakamoto S,Kamiyama M, Tanaka N, Mitsuzuka K, Kato T, Narita S, Yasumoto H, Teraoka S, Kato M, Osawa T, Nagumo
Y, Matsumoto H, Enokida H, Sugiyama T, Kuroiwa K, Inoue T, Sugimoto M, Mizowaki T, Kamoto T,Nishiyama H, Eto M, Japanese Urological Oncology Group: Novel metastatic burden- stratified risk
model in de novo metastatic hormone-sensitive prostate cancer. Cancer Sci. 2021 Sep; 112 (9): 36163626. [5y-IF: 6.622]

4. Shoji T, Niida Y, Osawa T, Matsumoto R, Sakurai K, Suzuki M, Matsuno Y, Konno S: Resolution of multifocal
micronodular pneumocyte hyperplasia with everolimus in a patient with tuberous sclerosis complex. Respir
Med Case Rep. 2021 Oct; 34: 101526. [5y-IF: N/A]

5. Takeda H, Matsumoto R, Takakuwa E, Hori K, Moriguchi T, Yamada S, Kikuchi H, Osawa T, Abe T, Shinohara N:
Favorable response to pembrolizumab in granulocyte colony-stimulating factor-producing upper urinary
tract urothelial carcinoma. IJU Case Rep. 2021 Dec; 5 (2): 108-112. [5y-IF: N/A]
6. Yamashita S, Kakimoto K, Uemura M, Kishida T, Kawai K, Nakamura T, Goto T, Osawa T, Yamada S,Nishimura K, Nonomura N, Nishiyama H, Shiraishi T, Ukimura O, Ogawa O, Shinohara N, Suzukamo Y, Ito A,
Arai Y: Health-Related Quality of Life in Testicular Cancer Survivors in Japan: A Multi-Institutional,
Cross-Sectional Study Using the EORTC QLQ-TC26. Urology. 2021 Oct; 156: 173-180. [5y-IF: 2.548]
7. Yamashita S, Kakimoto K, Uemura M, Kishida T, Kawai K, Nakamura T, Goto T, Osawa T, Yamada S,
Nishimura K, Nonomura N, Kojo K, Shiraishi T, Ukimura O, Ogawa O, Shinohara N, Suzukamo Y, Ito A, Arai Y:Fertility and reproductive technology use in testicular cancer survivors in Japan: A multi-institutional,cross-sectional study. Int J Urol. 2021 Oct; 28 (10): 1047-1052. [5y-IF: 3.011]

－121

2022
1. Ebina K, Abe T, Hotta K, Higuchi M, Furumido J, Iwahara N, Kon M, Miyaji K, Shibuya S, Lingbo Y, Komizunai
S, Kurashima Y, Kikuchi H, Matsumoto R, Osawa T, Murai S, Tsujita T, Sase K, Chen X, Konno A, Shinohara
N: Objective evaluation of laparoscopic surgical skills in wet lab training based on motion analysis andmachine learning. Langenbecks Arch Surg. 2022 Aug; 407 (5): 2123-2132. [5y-IF: 3.116]

2. Hirata Y, Higuchi M, Osawa T, Hinotsu S, Harabayashi T, Mochizuki T, Enami N, Nounaka O, Shinno Y,Kikuchi H, Matsumoto R, Abe T, Murai S, Shinohara N: Late recurrence in patients with non-muscleinvasive bladder cancer after 5-year cancer-free periods. Int J Urol. 2022 Oct; 29 (10): 1140-1146. [5yIF: 3.011]
3. Kikuchi H, Osawa T, Matsumoto R, Abe T, Maruyama S, Harabayashi T, Miyata H, Kashiwagi A, IkeshiroS, Sazawa A, Fukui R, Morita K, Takeuchi I, Hori K, Yamashita N, Minami K, Mochizuki T, Murai S,Shinohara N: Efficacy of nivolumab plus ipilimumab as first-line therapy for primary tumors inpatients with renal cell carcinoma. Urol Oncol. 2022 Jan; 40 (1): 13.e19-13.e27. [5y-IF: 3.011]

4. Kikuchi H, Abe T, Matsumoto R, Osawa T, Maruyama S, Murai S, Shinohara N: Outcomes of bacillus CalmetteGuérin therapy without a maintenance schedule for high-risk non-muscle-invasive bladder cancer in thesecond transurethral resection era. Int J Urol. 2022 Mar; 29 (3): 251-258. [5y-IF: 3.011]
5. Ebina K, Abe T, Hotta K, Higuchi M, Furumido J, Iwahara N, Kon M, Miyaji K, Shibuya S, Lingbo Y,

Komizunai S, Kurashima Y, Kikuchi H, Matsumoto R, Osawa T, Murai S, Tsujita T, Sase K, Chen X, Konno
A, Shinohara N: Automatic assessment of laparoscopic surgical skill competence based on motion
metrics. PLoS One. 2022 Nov; 17 (11): e0277105. [5y-IF: 4.069]
6. Numakura K, Nakai Y, Kojima T, Osawa T, Narita S, Nakayama M, Kitamura H, Nishiyama H, Shinohara N:
Overview of clinical management for older patients with renal cell carcinoma. Jpn J Clin Oncol. 2022 Jul;52 (7): 657-673. [5y-IF: 2.864]

7. Oishi Y, Kitta T, Osawa T, Abe T, Shinohara N, Nosato H, Sakanashi H, Murakawa M: Diagnosis and Localizationof Prostate Cancer via Automated Multiparametric MRI Equipped with Artificial Intelligence. Uro. 2022
2 (1): 21-29. [5y-IF: N/A]
8. Osawa T, Abe T, Kikuchi H, Matsumoto R, Murai S, Nakao T, Tanaka S, Watanabe A, Shinohara N: Validationof an online application to identify potential immune-related adverse events associated with immune
checkpoint inhibitors based on the patient's symptoms. PLoS One. 2022 Mar; 17 (3): e0265230. [5y-IF: 4.069]
9. Takayanagi A, Kato F, Nozaki A, Matsumoto R, Osawa T, Kuwahara K, Matsuno Y, Asano H, Kato T, Watari H,Abe T, Shinohara N, Kudo K: Imaging findings of ovarian metastasis of primary renal cell carcinoma: Acase report and literature review. Radiol Case Rep. 2022 May; 17 (7): 2320-2327. [5y-IF: N/A]－122

10. Yamada S, Abe T, Sazawa A, Katano H, Suzuki H, Takeuchi I, Ishizaki J, Minami K, Morita K, Tsuchiya K,Takada N, Maru S, Ishikawa S, Sato S, Kawazu T, Yamashita T, Ono T, Mochizuki T, Akino T, Sasaki Y, Shinno Y,Furumido J, Miyata H, Kikuchi H, Matsumoto R, Osawa T, Shinohara N: Comparative study of postoperativecomplications after radical cystectomy during the past two decades in Japan: Radical cystectomy remains
associated with significant postoperative morbidities. Urol Oncol. 2022 Jan; 40 (1): 11.e17-11.e25. [5y-IF:3.099]
11. Yamagata Y, Abe T, IwaharaN, Takada K, Hida Y, Takakuwa E, Kikuchi H, Matsumoto R, Osawa
T, Shinohara N: Metastatic neuroendocrine carcinoma of right adrenal glandsuccessfully treated withlaparoscopic adrenalectomy aftermultimodal therapy. IJU case reports. 2022 July; doi: https://doi.
org/10.1002/iju5.12511. [5y-IF: N/A]

－123